Sangamo Therapeutics
SGMO
#8725
Rank
โ‚ฌ0.14 B
Marketcap
0,43ย โ‚ฌ
Share price
-6.45%
Change (1 day)
-77.11%
Change (1 year)

Sangamo Therapeutics (SGMO) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : โ‚ฌ70.77 Million

According to Sangamo Therapeutics 's latest financial reports the company's total liabilities are โ‚ฌ70.77 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Sangamo Therapeutics - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31โ‚ฌ75.78 M1.63%
2023-12-31โ‚ฌ74.56 M-70.1%
2022-12-31โ‚ฌ0.24 B-18.5%
2021-12-31โ‚ฌ0.30 B-14.68%
2020-12-31โ‚ฌ0.35 B96.22%
2019-12-31โ‚ฌ0.18 B-6.28%
2018-12-31โ‚ฌ0.19 B136.78%
2017-12-31โ‚ฌ82.37 M299.38%
2016-12-31โ‚ฌ20.62 M-9.05%
2015-12-31โ‚ฌ22.67 M-24.6%
2014-12-31โ‚ฌ30.07 M117.15%
2013-12-31โ‚ฌ13.85 M3.88%
2012-12-31โ‚ฌ13.33 M140.36%
2011-12-31โ‚ฌ5.54 M4.04%
2010-12-31โ‚ฌ5.33 M-51.21%
2009-12-31โ‚ฌ10.92 M22.67%
2008-12-31โ‚ฌ8.9 M10.44%
2007-12-31โ‚ฌ8.06 M50.44%
2006-12-31โ‚ฌ5.36 M-43.13%
2005-12-31โ‚ฌ9.42 M444.71%
2004-12-31โ‚ฌ1.73 M38.72%
2003-12-31โ‚ฌ1.24 M-34.15%
2002-12-31โ‚ฌ1.89 M-37.27%
2001-12-31โ‚ฌ3.02 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Gilead Sciences
GILD
โ‚ฌ31.84 B 44,896.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
โ‚ฌ3.96 B 5,504.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚ฌ69.16 B 97,620.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚ฌ9.44 B 13,249.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
โ‚ฌ36.01 B 50,781.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚ฌ97.51 B 137,690.05%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚ฌ1.33 B 1,790.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ66.68 B 94,122.09%๐Ÿ‡บ๐Ÿ‡ธ USA